Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Carl Lebel > Profile

Carl Lebel

Affiliations

Chief Development Officer at Frequency Therapeutics Inc. (FREQ), 2023-01-27
Chief Scientific Officer at Otonomy Inc. (OTIC), 2016-11-22
Director at Nurx Pharmaceuticals Inc. (NUXP.OB), 2010-02-24

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
FREQ	$1.52	4,421	$6,719.92	26,343	2022-07-06	Filing
FREQ	$3.53	1,069	$3,772.50	11,126	2022-02-22	Filing
FREQ	$3.87	974	$3,772.30	12,195	2022-02-18	Filing
FREQ	$4.19	901	$3,774.29	13,169	2022-02-17	Filing
FREQ	$4.43	831	$3,680.50	14,070	2022-02-16	Filing